FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Democrat Lawmakers Probe FDA Voucher Program

[ Price : $8.95]

U.S. House and Senate health committee leaders express concern about a new FDA review pilot program because it appears designed to...

FDA Finds Sterility Lapses at NJ Drug Outsourcer

[ Price : $8.95]

FDA investigators cite Molecular PharmaGroup, an outsourcing facility in New Providence, N.J., for multiple sterility and quality-...

Alert on Misassembled Fresenius Infusion Pump Components

[ Price : $8.95]

FDA issues an early alert warning about a potentially high-risk defect in certain Fresenius Kabi Ivenix large volume pump primary ...

J&J Scraps Alzheimers Trial After Disappointing Data

[ Price : $8.95]

Johnson & Johnson discontinues its Auτonomy Phase 2b Alzheimers study after interim data showed its experimental antibody pos...

Woodcock Urges Stronger FDA Role in Updating Generic Labels

[ Price : $8.95]

Former FDA principal deputy commissioner Janet Woodcock and policy experts from Duke University call on the agency to adopt new to...

FDA Probes Death Associated With Takedas Adzynma

[ Price : $8.95]

FDA investigates the death of a pediatric patient with congenital thrombotic thrombocytopenic purpura who developed neutralizing a...

Sterility Failures Flagged at Indian Injectable Drug Maker

[ Price : $8.95]

FDA investigators cite Immacule Lifesciences Private Limited, a sterile drug contract manufacturer in Himachal Pradesh, India, for...

White House Sought Resignation of Top Makary Aide

[ Price : $8.95]

New reporting finds that the White House recently requested the resignation of a senior aide to FDA commissioner Marty Makary, hig...

Intersurgical Recalls Video Laryngoscope Due to Safety

[ Price : $8.95]

Intersurgical recalls (Class 1) its i-View Video Laryngoscope, citing serious safety risks that could potentially lead to severe i...

Voucher Program Looks Like a Make-a-Deal Process: Experts

[ Price : $8.95]

Three Harvard medical professors raise concerns over FDAs review voucher program that they say could politicize drug approvals and...